» Articles » PMID: 35858441

Pain Hypersensitivity in a Pharmacological Mouse Model of Attention-deficit/hyperactivity Disorder

Overview
Specialty Science
Date 2022 Jul 20
PMID 35858441
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical evidence suggests that pain hypersensitivity develops in patients with attention-deficit/hyperactivity disorder (ADHD). However, the mechanisms and neural circuits involved in these interactions remain unknown because of the paucity of studies in animal models. We previously validated a mouse model of ADHD obtained by neonatal 6-hydroxydopamine (6-OHDA) injection. Here, we have demonstrated that 6-OHDA mice exhibit a marked sensitization to thermal and mechanical stimuli, suggesting that phenotypes associated with ADHD include increased nociception. Moreover, sensitization to pathological inflammatory stimulus is amplified in 6-OHDA mice as compared to shams. In this ADHD model, spinal dorsal horn neuron hyperexcitability was observed. Furthermore, ADHD-related hyperactivity and anxiety, but not inattention and impulsivity, are worsened in persistent inflammatory conditions. By combining in vivo electrophysiology, optogenetics, and behavioral analyses, we demonstrated that anterior cingulate cortex (ACC) hyperactivity alters the ACC-posterior insula circuit and triggers changes in spinal networks that underlie nociceptive sensitization. Altogether, our results point to shared mechanisms underlying the comorbidity between ADHD and nociceptive sensitization. This interaction reinforces nociceptive sensitization and hyperactivity, suggesting that overlapping ACC circuits may be targeted to develop better treatments.

Citing Articles

Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain.

Kasahara S, Takahashi M, Suto T, Morita T, Obata H, Niwa S Front Pharmacol. 2025; 16:1500313.

PMID: 40078279 PMC: 11896983. DOI: 10.3389/fphar.2025.1500313.


Overactive PKA signaling underlies the hyperalgesia in an ADHD mouse model.

Kerosi D, Yin Y, Gu P, Liu D, Deng M, Li J iScience. 2024; 27(11):111110.

PMID: 39507260 PMC: 11539593. DOI: 10.1016/j.isci.2024.111110.


Precuneal hyperperfusion in patients with attention-deficit/hyperactivity disorder-comorbid nociplastic pain.

Takahashi M, Kasahara S, Soma T, Morita T, Sato N, Matsudaira K Front Pharmacol. 2024; 15:1480546.

PMID: 39484159 PMC: 11524990. DOI: 10.3389/fphar.2024.1480546.


Multiple Posterior Insula Projections to the Brainstem Descending Pain Modulatory System.

Liang D, Labrakakis C Int J Mol Sci. 2024; 25(17).

PMID: 39273133 PMC: 11395413. DOI: 10.3390/ijms25179185.


Modulating Neural Circuits of Pain in Preclinical Models: Recent Insights for Future Therapeutics.

Viellard J, Bouali-Benazzouz R, Benazzouz A, Fossat P Cells. 2024; 13(12.

PMID: 38920628 PMC: 11202162. DOI: 10.3390/cells13120997.


References
1.
Faraone S, Sergeant J, Gillberg C, Biederman J . The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry. 2006; 2(2):104-13. PMC: 1525089. View

2.
Bledsoe J, Semrud-Clikeman M, Pliszka S . Anterior cingulate cortex and symptom severity in attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2013; 122(2):558-65. DOI: 10.1037/a0032390. View

3.
Woolf C, Salter M . Neuronal plasticity: increasing the gain in pain. Science. 2000; 288(5472):1765-9. DOI: 10.1126/science.288.5472.1765. View

4.
Davids E, Zhang K, Tarazi F, Baldessarini R . Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003; 42(1):1-21. DOI: 10.1016/s0165-0173(02)00274-6. View

5.
Eliava M, Melchior M, Knobloch-Bollmann H, Wahis J, Da Silva Gouveia M, Tang Y . A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing. Neuron. 2016; 89(6):1291-1304. PMC: 5679079. DOI: 10.1016/j.neuron.2016.01.041. View